images

serotonin and its receptor as a new antioxidant

Serotonin and Its Receptor as a New Antioxidant ... Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease J Diabetes Res. 2017;2017:7680576. doi: 10.1155/2017/7680576. Epub 2017 Aug 8. Authors Yu Yan

Get More

Serotonin and Its Receptor as a New Antioxidant ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease J Diabetes Res. 2017;2017:7680576. doi: 10.1155/2017/7680576. Epub 2017 Aug 8. Authors Yu Yang 1 ... Receptors, Serotonin Serotonin ...

Leave a Message

Serotonin and Its Receptor as a New Antioxidant ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease. Yang Y(1), Huang H(1)(2), Xu Z(2)(3), Duan JK(4). Author information: (1)Department of Endocrinology, Metabolism, and Genetics, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China.

Leave a Message

Serotonin and Its Receptor as a New Antioxidant ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Yu Yang , 1 Hui Huang , 1 , 2 Zheng Xu , 2 , 3 and Jun-kai Duan 4 1 Department of Endocrinology, Metabolism, and Genetics, Jiangxi Provincial Children’s Hospital, Nanchang, Jiangxi, China

Leave a Message

Serotonin and Its Receptor as a New Antioxidant ...

Review Article Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Yu Yang,1 Hui Huang,1,2 Zheng Xu,2,3 and Jun-kai Duan4 1Department of Endocrinology, Metabolism, and Genetics, Jiangxi Provincial Children’s Hospital, Nanchang, Jiangxi, China 2Pediatric Research Institute, Department of Pediatrics, University of Louisville, Louisville, KY, USA

Leave a Message

Serotonin and Its Receptor as a New Antioxidant ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease. Yu Yang, 1 , * Hui Huang, 1 , 2 Zheng Xu, 2 , 3 and Jun-kai Duan 4 ... , and central serotonin 2C receptors regulated glucose homeostasis and may represent a rational target for type 2 diabetes (T2DM) treatment [53, 54].

Leave a Message

[PDF] Serotonin and Its Receptor as a New Antioxidant ...

Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30–50% of patients, and represents a leading cause of death of DM. Serotonin or 5-hydroxytryptamine (5-HT) is a multifunctional bioamine that has crucial roles in many physiological pathways. Recently, emerging evidence from experimental and clinical studies has ...

Leave a Message

(PDF) Serotonin and Its Receptor as a New Antioxidant ...

PDF | Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30–50% of patients, and... | Find, read and cite all the research ...

Leave a Message

Serotonin and Its Receptor as a New Antioxidant ...

Free Online Library: Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease.(Report) by "Journal of Diabetes Research"; Health, general Antioxidants Health aspects Physiological aspects Antioxidants (Nutrients) Chronic kidney failure Causes of Complications and side effects Diagnosis Diabetes mellitus Diabetic nephropathies Risk factors Kidney diseases ...

Leave a Message

Serotonin and Its Receptor as a New Antioxidant ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease. Source: NCBI PubMed ( ID PMID:28929122)

Leave a Message

Serotonin and Its Receptor as a New Antioxidant ...

Review Article Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Yu Yang,1 Hui Huang,1,2 Zheng Xu,2,3 and Jun-kai Duan4 1 Department of Endocrinology, Metabolism, and Genetics, Jiangxi Provincial Children’s Hospital, Nanchang, Jiangxi, China Pediatric Research Institute, Department of Pediatrics ...

Leave a Message

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic ... - Mendeley

(2017) Yang et al. Journal of Diabetes Research. Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30-50% of patients, and represents a leading cause of death of DM. Serotonin or 5-hydroxytryptamine (5-HT) is a multifunction...

Leave a Message

NDLI: Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease. Access Restriction Open. Requires : PDF viewer Plugin. Author:

Leave a Message

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney ...

Review Article Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Yu Yang,1 Hui Huang,1,2 Zheng Xu,2,3 and Jun-kai Duan4 1 Department of Endocrinology, Metabolism, and Genetics, Jiangxi Provincial Children’s Hospital, Nanchang, Jiangxi, China Pediatric Research Institute, Department of Pediatrics ...

Leave a Message

serotonin and its receptor as a new antioxidant

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Watts, " 5-Hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT)," Clinical and Experimental Pharmacology and Physiology, vol.

Leave a Message

Holdings: Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease . Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30–50% of patients, and represents a leading cause of death of DM.

Leave a Message

Figure 4 | Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Figure 4 Illustration to show the mechanism of 5-HT1D and 5-HT2AR in human T2DM. 5-HT1DR and 5-HT1AR messenger RNA expression was increased in human T2DM islets.

Leave a Message

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease . By Yu Yang, Hui Huang, Zheng Xu and Jun-kai Duan. Cite . BibTex; Full citation; Publisher: Hindawi Limited. Year: 2017. DOI identifier: 10.1155/2017/7680576. OAI identifier: Provided by: MUCC ...

Leave a Message

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Journal of Diabetes Research , Aug 2017 Yu Yang , Hui Huang , Zheng Xu , Jun-kai Duan

Leave a Message

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney ...

Related papers. Page number / 10 10

Leave a Message

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney ...

We are not allowed to display external PDFs yet. You will be redirected to the full text document in the repository in a few seconds, if not click here.click here.

Leave a Message

Holdings: Serotonin and Its Receptor as a New Antioxidant ...

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease . Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30–50% of patients, and represents a leading cause of death of DM.

Leave a Message

Antioxidant and Membrane Binding Properties of Serotonin ...

Introduction. Oxidation of cellular components such as DNA, proteins, or lipids is associated with a number of physiopathological situations and degenerative diseases (1, 2, 3, 4).Among those oxidation reactions, lipid peroxidation (LPO) has important cellular consequences because it may alter the permissive barrier function of the membrane and its capacity to harbor a regulated signaling ...

Leave a Message

Serotonin and its Receptors in the Human CNS with New ...

Serotonin (5-hydroxytryptamine, 5-HT) is well known to be closely associated with emotional disorders, such as depression and schizophrenia. The seven main...

Leave a Message

Serotonin and its receptors in the human CNS with new ...

Serotonin (5-hydroxytryptamine, 5-HT) is well known to be closely associated with emotional disorders, such as depression and schizophrenia. The seven main members of 5-HT receptor family including the different subtypes are involved in the functional pathways in the brain and their balance in activity helps to maintain the normal mental stability.

Leave a Message

The role of serotonin and its receptors in activation of ...

Serotonin or 5-hydroxytryptamine (5-HT) is a neurotransmitter and hormone that contributes to the regulation of various physiological functions by its actions in the central nervous system (CNS) and in the respective organ systems. Peripheral 5-HT is predominantly produced by enterochromaffin (EC) cells of the gastrointestinal (GI) tract.

Leave a Message

(PDF) Effect Antioxidant and Serotonin Level in the Sera ...

PDF | On Jan 1, 2019, Ahmed Chyad Abbas and others published Effect Antioxidant and Serotonin Level in the Sera on Type II Diabetes Mellitus Males Patients and Compare with Control Group | Find ...

Leave a Message

Understanding Serotonin 5-HT2A Receptors-regulated ...

Yang Y, Huang H, Xu Z, Duan JK. Serotonin and its receptor as a new antioxidant therapeutic target for diabetic kidney disease. J diabetes res. 2017;2017. 37. Garnovskaya MN, Mukhin YV, Turner JH, Vlasova TM, Ullian ME, Raymond JR. Mitogen-induced activation of Na+/H+ exchange in vascular smooth muscle cells involves Janus kinase 2 and Ca2 ...

Leave a Message

Peripheral 5-HT7 receptors as a new target for prevention ...

Serotonin (5-hydroxytryptamine, 5-HT) is a biogenic monoamine with a variety of functions in many physiological and pathophysiological processes (Yang et al. 2006). It is well established that various biological effects of 5-HT are mediated through different serotonin receptors and their signal transduction pathways (MaassenVanDenBrink et al ...

Leave a Message

Serotonin and its metabolites reduce oxidative stress in ...

In this study, we focused on comparing the effects of serotonin and its metabolites on the functions of RAW264.7 cells (emphasis on oxidative burst and production of nitric oxide and cytokines), thereby expanding the scope of existing knowledge with advent of novel findings in this field. Changes in production of reactive oxygen species (ROS) by RAW264.7 cells after treatment with serotonin, N ...

Leave a Message

A new hypertrophic mechanism of serotonin in cardiac ...

In the present study, we identified a novel mechanism of cardiac myocyte hypertrophy by serotonin. This mechanism is independent of receptor stimulation and requires serotonin uptake into cardiomyocytes, its degradation by the mitochondrial enzyme monoamine oxidase A, hydrogen peroxide production, and ERK phosphorylation.

Leave a Message

Leave a Message